On 30 May 2017
Sword & Shield Pharma will hold a meeting of the Board of Directors of the Company on 30 May 2017, to consider and approve the Audited Financial Results for the quarter and year ended March 31, 2017.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
